Silver Nanoparticles Effective Against Tuberculosis Bacteria
In this study abstract, entitled “Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis” the authors state that by capping silver nanoparticles with bovine serum albumin and then testing it in the laboratory against “clinical isolates collected from TB endemic areas” (i.e., sputum samples collected from pulmonary TB patients) they were able to demonstrate that this novel nanosilver compound constitutes a “potent anti-TB drug.”
In the full study, which is available through the journal Current Microbiology (2011, 62:715-726), the authors further state, “Encouragingly, the results indicate that this novel design could be further extended for developing improved medicinal agents for combating multi-drug-resistant TB.”
